Majowicz, SE, et al.
The global burden of nontyphoidal Salmonella gastroenteritis. Clinical Infectious Diseases
2010; 50: 882–889.
Zhang-Barber, L, et al.
Vaccination for control of Salmonella in poultry. Vaccine
1999; 17: 2538–2545.
Thomas, ME, et al.
Quantification of horizontal transmission of Salmonella enterica serovar Enteritidis bacteria in pairhoused groups of laying hens. Applied Environmental Microbiology
2009; 75: 6361–6366.
Salmonella infections: immune and non-immune protection with vaccines. Avian Pathology
2007; 36: 1–13.
Cogan, TA, et al.
The rise and fall of Salmonella Enteritidis in the UK. Journal Applied Microbiology
2003; 94: 114S–119S.
Collard, JM, et al.
Drastic decrease of Salmonella Enteritidis isolated from humans in Belgium in 2005, shift in phage types and influence on foodborne outbreaks. Epidemiology and Infection
2008; 136: 771–781
Ingolotti, M, et al.
DNA vaccines for targeting bacterial infections. Expert Review of Vaccines
2010; 9: 747–763.
Blondel, CJ, et al.
Contribution of the type VI secretion system encoded in SPI-19 to chicken colonization by Salmonella enterica serotypes Gallinarum and Enteritidis. PLoS ONE
2010; 5: e11724.
Cascales, E. The type VI secretion toolkit. EMBO Reports
2008; 9: 735–741.
Basler, M, et al.
Type VI secretion requires a dynamic contractile phage tail-like structure. Nature
2012; 483: 182–186.
Schell, M, et al.
Type VI secretion is a major virulence determinant in Burkholderia mallei
. Molecular Microbiology
2007; 64: 1466–1485.
Santiviago, C, et al.
Spontaneous excision of the Salmonella enterica serovar Enteritidis-specific defective prophage-like element phiSE14. Journal of Bacteriology
2010; 192: 2246–2254.
Agron, PG, et al.
Identification by subtractive hybridization of sequences specific for Salmonella enterica serovar Enteritidis. Applied and Environmental Microbiology
2001; 67: 4984–4991.
Mbow, ML, et al.
New adjuvants for human vaccines. Current Opinion in Immunology
2010; 22: 411–416.
Arrach, N, et al.
High-throughput screening for Salmonella avirulent mutants that retain targeting of solid tumors. Cancer Research
2010; 70: 2165–2170.
Hao, L-Y, et al.
Requirement of siderophore biosynthesis for plant colonization by Salmonella enterica
. Applied and Environmental Microbiology
2012; 78: 4561–4570.
Thomson, NR, et al.
Comparative genome analysis of Salmonella Enteritidis PT4 and Salmonella Gallinarum 287/91 provides insights into evolutionary and host adaptation pathways. Genome Research
2008; 18: 1624–1637.
Robinson, K, et al.
Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infection and Immunity
2004; 72: 2753–2761.
Asahi-Ozaki, Y, et al.
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection. Microbes Infect
2006; 8: 2706–2714.
Olive, C, et al.
Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation. Vaccine
2007; 25: 1789–1797.
Retamal-Díaz, A, et al.
S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol use as adjuvant improved protective immunity to a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice. Clinical and Vaccine Immunology
2014; 21: 1474–1480.
Oñate, A, et al.
A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c Mice. Infection and Immunity
2003; 71: 4857–4861.
Heithoff, DM, et al.
Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity. Infection and Immunity
2008; 76: 5191–5199.
Araya, DV, et al.
Deletion of a prophage-like element causes attenuation of Salmonella enterica serovar Enteritidis and promotes protective immunity. Vaccine
2010; 28: 5458–5466.
Kim, S-H, et al.
Mucosal immune system and M cell-targeting strategies for oral mucosal vaccination. Immune Network
2012; 12: 165–175.
Michetti, P, et al.
Monoclonal immunoglobulin A prevents adherence and polarized epithelial cell monolayers by Salmonella typhimurium
1994; 107: 915–923.
Forbes, SJ, et al.
Inhibition of Salmonella enterica serovar typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody. Infection and Immunity
2008; 76: 4137–4144.
Borges, O, et al.
Mucosal vaccines: recent progress in understanding the natural barriers. Pharmaceutical Research
2010; 27: 211–223.
McSorley, SJ, et al.
Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium. Infection and Immunity
2000; 68: 3344–3348.
Mittrücker, HW, et al.
Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. Journal of Immunology
2000; 164: 1648–1652.
Mastroeni, P, et al.
Igh-6-/- (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar Typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infection and Immunity
2000; 68: 46–53.
Igietseme, JU, et al.
Antibody regulation of T cell immunity: implications for vaccine strategies against intracellular pathogens. Expert Review of Vaccines
2004; 3: 23–34.
Mosmann, TR. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Advances in Immunology
1989; 46: 111–116.
Abbas, AK, et al.
Functional diversity of helper T lymphocytes. Nature
1996; 383: 787–793
Nimmerjahn, F, et al.
FcγRIV: a novel FcR with distinct IgG subclass specificity. Immunity
2005; 23: 41–51.
Fransen, F, et al.
Agonists of Toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B. Infection and Immunity
2007; 75: 5939–5946.
Mittrücker, H-W, et al.
Characterization of the murine T-Lymphocyte response to Salmonella enterica serovar Typhimurium infection. Infection and Immunity
2002; 70: 199–203.
Kirby, AC, et al.
In vivo compartmentalization of functionally distinct, rapidly responsive antigen-specific T-cell populations in DNA-immunized or Salmonella enterica serovar Typhimurium-infected mice. Infection and Immunity
2004; 72: 6390–6400.
Akdis, M, et al.
Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. Journal of Allergy and Clinical Immunology
2011; 127: 701–721.
Harrison, J, et al.
Correlates of protection induced by live Aro-
Salmonella typhimurium vaccines in the murine typhoid model. Immunology
1997; 90: 618–625.
Nagarajan, AG, et al.
sopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine condidate in conjugation with live attenuated bacteria. Vaccine
2009; 27: 2804–2811.